4DMedical Limited (ASX:4DX)
Australia · Delayed Price · Currency is AUD 3.990
-0.080 (-1.97%)
Oct 7, 2026, 4:10 PM AEST
4DMedical Market Cap
4DMedical has a market cap or net worth of 2.4 billion as of October 7, 2026. Its market cap has increased by 111.95% in one year.
Market Cap
2.40B
Enterprise Value
2.30B
Revenue
7.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.99
ChartMarket Cap Chart
Since August 7, 2020, 4DMedical's market cap has increased from 420.97M to 2.40B, an increase of 470.17%. That is a compound annual growth rate of 32.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 2.40B | 14.43% |
| Dec 31, 2025 | 2.10B | 961.67% |
| Dec 31, 2024 | 197.57M | -29.31% |
| Dec 29, 2023 | 279.48M | 125.82% |
| Dec 30, 2022 | 123.76M | -68.87% |
| Dec 31, 2021 | 397.56M | -38.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cochlear | 8.47B |
| PolyNovo | 618.30M |
| Imricor Medical Systems | 520.04M |
| EBR Systems | 207.14M |
| Aroa Biosurgery | 185.06M |
| EMVision Medical Devices | 145.01M |
| Saluda Medical | 104.59M |
| Lumos Diagnostics Holdings | 94.48M |